摘要
目的观察新一代光动力治疗联合化疗治疗肺癌伴大量胸腔积液的疗效及护理作用探讨。方法选择经组织学和(或)细胞学确诊的肺癌伴胸腔积液患者71例作为观察组,另选同期经CT或B型超声或胸部X线片确诊的肺癌伴胸腔积液患者63例作为对照组。观察组采用新一代光动力治疗联合常规化疗进行治疗,对照组单用化疗治疗。比较2组临床疗效及不良反应发生情况。结果观察组总有效率为85.9%高于对照组的55.6%,差异有统计学意义(P<0.05);2组均未出现明显不良反应。结论新一代光动力治疗联合常规化疗治疗肺癌伴大量胸腔积液安全、有效、毒副作用小;良好的护理对保证光动力治疗恶性肿瘤的顺利进行起着非常重要的作用。
Objective To explore the clinical efficacy of the new generation of photodynamic combination chemotherapy in lung cancer combined with massive pleural effusion.Methods Selected 71 cases patients with lung cancer combined with massive pleural effusion as observation group,which were diagnosised by a new generation of photodynamic combination chemotherapy,and selected 63 cases patients with lung cancer combined with massive pleural effusion as control group,which were diagnosised by CT,B-mode ultrasound,and X-ray.Observation group was given by a new generation of photodynamic combination chemotherapy,control group was given chemotherapy.After treatment,compared the effect and adverse reactions of 2 groups.Results The total effective rate of observation group（85.9%） was higher than that of control group（55.6%）,the difference was statistically significance（P 0.05）.Conclusion The new generation of photodynamic combination chemotherapy is safe,effective,and drug side effect;Good care measures play an important role in the treatment.
出处
《临床合理用药杂志》
2013年第1期24-25,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
肺癌
胸腔积液
新一代光动力治疗
化疗
护理
Lung cancer
Pleural effusion
New generation of photodynamic therapy
Chemotherapy
Care
